|
Volumn 172, Issue 15, 2012, Pages 1186-1187
|
Prescription drug abuse and DEA-sanctioned drug take-back events: Characteristics and outcomes in rural appalachia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZODIAZEPINE;
BUTALBITAL;
CENTRAL STIMULANT AGENT;
DEXTROPROPOXYPHENE PLUS PARACETAMOL;
DICHLORALPHENAZONE;
DRONABINOL;
FENTANYL;
HYDROCODONE;
HYDROMORPHONE;
HYPNOTIC SEDATIVE AGENT;
ILLICIT DRUG;
ISOMETHEPTENE MUCATE;
METHADONE;
MODAFINIL;
OPIATE;
OXYCODONE;
OXYCODONE PLUS OXYCODONE TEREPHTHALATE PLUS PARACETAMOL;
PARACETAMOL;
PETHIDINE;
PHENTERMINE;
PREGABALIN;
SPASMOLYTIC AGENT;
TESTOSTERONE;
TRAMADOL;
ADULT;
AGE DISTRIBUTION;
ANALGESIA;
ARTICLE;
CONTROLLED STUDY;
DRUG ABUSE;
DRUG APPROVAL;
DRUG CONTROL;
DRUG INTOXICATION;
DRUG RECALL;
FEMALE;
GOVERNMENT;
HUMAN;
LEGAL ASPECT;
MAJOR CLINICAL STUDY;
MALE;
MOTIVATION;
PRESCRIPTION;
PRIORITY JOURNAL;
RURAL AREA;
SEX RATIO;
TAKE BACK EVENT;
TREATMENT OUTCOME;
UNITED STATES;
ANALGESICS, OPIOID;
APPALACHIAN REGION;
DRUG AND NARCOTIC CONTROL;
GOVERNMENT REGULATION;
HUMANS;
PRESCRIPTION DRUG MISUSE;
PRESCRIPTION DRUGS;
RURAL POPULATION;
SUBSTANCE-RELATED DISORDERS;
|
EID: 84865683795
PISSN: 00039926
EISSN: 15383679
Source Type: Journal
DOI: 10.1001/archinternmed.2012.2374 Document Type: Article |
Times cited : (38)
|
References (6)
|